In addition, MEG3 has been widely studied in the context of ER stress in various cancers like breast cancer, cervical carcinoma, and colorectal carcinoma and can act as the potential therapeutic target for the prevention of tumor progression [47–49]. This evidence concerns the gene MEG3 and breast cancer.